New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2014
20:42 EDTHSP, AKRXHospira, Orion sue Akorn to halt generic launch of Precedex, Bloomberg says
Hospira and Finnish drug company Orion Oyj have accused Akorn of infringing on the patent for the sedative Precedex, says Bloomberg.
News For HSP;AKRX From The Last 14 Days
Check below for free stories on HSP;AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
17:12 EDTHSPOn The Fly: Closing Wrap
Subscribe for More Information
13:00 EDTHSPFollow-up: Hospira upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
12:24 EDTHSPHospira upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
09:28 EDTHSPHospira sees FY14 gross margin 39%-40%
Subscribe for More Information
07:35 EDTHSPHospira sees FY14 adjusted EPS $2.30-$2.50, consensus $2.22
Raises FY14 cash flow from operations to $275M-$375M from $200M-$300M; Backs FY14 CapEx $375M-$425M; Backs FY14 depreciation and amortization to range $225M-$275M.
07:34 EDTHSPHospira reports Q2 adjusted EPS 72c, consensus 57c
Subscribe for More Information
July 29, 2014
15:53 EDTHSPNotable companies reporting before tomorrow's open
Subscribe for More Information
07:19 EDTHSPCBI to hold a conference
Subscribe for More Information
July 28, 2014
12:42 EDTHSPHospira, Danone rise following report of deal talks
Subscribe for More Information
08:12 EDTHSPHospira to obtain financial benefits from possible Danone deal, says Wells Fargo
After multiple media sources reported that Hospira (HSP) is in talks to buy Danone's (DANOY) medical nutrition business in a potential tax inversion deal, Wells Fargo estimates that the deal could be 9%-12% accretive to Hospira's EPS in 2015-2017 if it's an all-stock deal and 20%-22% accretive if it's a 50%/50% cash and stock deal. The firm The firm estimates that Hospira's tax bill would be cut to 21% in 2015 and 19% afterwards, from its current forecast of 24%-26% during those years. The firm thinks the strategic rationale for the deal from Hospira's perspective, however, is less clear. It keeps a Market Perform rating on the stock.
July 27, 2014
15:12 EDTHSP Hospira in talks to acquire Danone medical nutrition business, FT says
French consumer company Danone (DANOY) has been in negotiations to sell its medical nutrition business to Hospira (HSP) in a deal said to value the unit at $5B, says the Financial Times. The deal would also allow for U.S. based Hospira to domicile its tax base in Europe in a tax strategy known as an inversion, added the Financial Times. In prior reports, Nestle (NSRGY) and Fresenius (FMS) have also been mentioned as suitors for the Danone unit. Reference Link
July 23, 2014
10:02 EDTHSPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTHSPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTHSPHospira initiated with a Hold at Deutsche Bank
Target $53.
July 18, 2014
10:48 EDTHSPHigh option volume stocks
Subscribe for More Information
July 17, 2014
09:28 EDTAKRXAkorn recent pullback a buying opportunity, says Craig-Hallum
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use